Headquarters in India

Cipla website:

🔎 Run a search for “Cipla”

Get RSS feed of these results

All stories

13 February 2017

India: 2017 Responsible Business Index ranks top 100 listed companies

In an attempt to gauge how Indian firms are coping with the interests of various stakeholders, a collaborative effort of non-profits—Oxfam India, Corporate Responsibility Watch, Praxis and Partners in Change—has put together the second edition of India...

See full story

19 January 2016
+ Français - Hide
20 January 2015

India: Report on companies' sustainability practices - an analysis of the top 100 listed companies

Author: Price Waterhouse Coopers Pvt. Ltd.

SEBI’s regulation in 2012 mandating the top 100 listed companies to report on their performance on the Business Responsibility Guidelines through Business Responsibility Reports (BRRs), along with their Annual Reports...The report sets out to document...

Read more

19 April 2012

TAC asks Supreme Court of Appeal to consider public health in patent dispute over cancer medicine [So. Africa]

Author: Treatment Action Campaign [So. Africa]

The [Treatment Action Campaign]...has resolved to seek admission in a legal dispute between...Aventis Pharma [part of Sanofi] and...Cipla, over a claim of patent infringement on a drug that treats cancer called Docetaxel...TAC is arguing that when the ...

Read more

25 March 2012

Drug companies watching India’s drug patent case

Author: Stephanie Nolen, Globe & Mail [Canada]

India’s Supreme Court will hear final arguments…in a case that could have life-or-death implications for millions…Novartis...wants to patent…a leukemia drug…In 2006, the Indian Patent Office denied that…saying…it was not a new medicine…Novartis took...

Read more

30 November 2010

Cipla develops Mother-Baby Pack for preventing mother-to-child transmission of HIV/AIDS

Author: India Infoline News Service

Cipla…has developed the first-of-its kind ‘Mother-Baby Pack’ in collaboration with UNICEF... The Mother-Baby Pack contains the entire range of anti-retroviral drugs and antibiotics required by an HIV infected mother starting from the 14th week of...

Read more

20 June 2010

European drug companies lead 'Access to Medicine Index'

Author: Access to Medicine Index

…The Access to Medicine Index ranks 20 of the world's largest pharmaceutical companies on their efforts to make sure that medicines are made for, and reach, people in developing countries…The Access to Medicine Index 2010 identifies GlaxoSmithKline as...

Read more

20 August 2009

Big Pharma must mend its ways to succeed in India

Author: Pillman, DNA [India]

Close on the heels of the Intellectual Property Appellate Board halting Novartis' Glivec patent application...on account of its high prices, the Delhi High Court has dealt a body blow to German drug maker Bayer's ambitions to monopolise the Indian...

Read more

19 August 2009

HC rejects Bayer’s plea [India]

Author: Rupali Mukherjee, Times of India

Promoting consumers access to affordable medicines, the Delhi High Court...rejected pharma MNC Bayer's petition, which had indirectly sought ‘patent linkage'... patent linkages mean that no marketing approval is given for generic versions of medicines,...

Read more

18 August 2009

Bayer Corporation vs. Union of India [Delhi High Court Judgment]

Author: High Court of Delhi

Bayer states that Cipla’s generic version of Sorafanib, which, it is contended, is sold under the brand name “Soranib” would amount to a “spurious drug”. If Bayer’s contention were to prevail, every generic drug would ipso facto amount to a “spurious...

Read more